Fluctuation in Weight May Influence Risk Certain Cancers (4/10/2008)
Researchers in Austria have reported that large weight gains or losses may influence an individual’s risk for developing certain types of cancer. Complete details of the study were published in the April 2008 issue of the Annals of Oncology.

Neulasta® on First Day of Chemotherapy May Be More Convenient for Gynecologic Cancers (3/18/2008)
Researchers from the University of Alabama have reported that the administration of Neulasta® (pegfilgrastim) on the first day of chemotherapy among women with gynecologic cancers may be as effective as and more convenient than second-day administration. These results were recently reported at the 2008 annual Society of Gynecologic Oncologists meeting.

Thalomid® Improves Response to Hycamtin® for Recurrent Ovarian Cancer (3/4/2008)
Researchers from the University of Minnesota have reported that the addition of Thalomid® (thalidomide) to Hycamtin® (topotecan) improves response rate in women with recurrent ovarian cancer. The details of this study were published in the January 15, 2008 issue of Cancer.

Test Evaluating Combination of Biomarkers Highly Accurate in Detecting Ovarian Cancer (2/21/2008)
Researchers from several US medical centers have reported that a test evaluating a combination of six biomarker appears to be highly accurate in detecting ovarian cancer. These results were recently published in the February 15, 2008 issue of Clinical Cancer Research.

Experience of Technician Affects Accuracy of Gynecologic Ultrasound in Ovarian Cancer Screening (2/15/2008)
Researchers from the UK have reported that the expertise of the technician performing gynecologic  ultrasound not only affects the accuracy of the test results but also initial management of patients with suspected ovarian cancer. These results were published in the February 2008 issue of The Lancet Oncology.